OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
June 21, 2016.
Over the next week, pharma companies will be disclosing details of collaborations with health professionals (HCPs) and healthcare organizations (HCOs) across Europe, as EFPIA's end-of-June deadline date for full disclosure of transfer-of-value payments draws near.
Covering activities such as research and educational grants to healthcare organizations, as well as transfers of value to individuals for activities such as speaking at educational meetings, consultancy and attending advisory boards as well as sponsorship to attend educational meetings, the first disclosures will address transfers of value made during 2015.
Director General of EFPIA, Richard BergstrÃ¶m said, “Increasing transparency through the individual disclosure of transfers of value is good for everyone, including healthcare professionals because it builds understanding of this important collaboration. When pharmaceutical companies research, develop and introduce new medicines in to clinical practice, it requires input from many stakeholders such as health professionals and healthcare organizations. The introduction of the EFPIA Disclosure Code helps to increase understanding of these important relationships.”